1. Home
  2. ITOC vs ISPC Comparison

ITOC vs ISPC Comparison

Compare ITOC & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ITOC

iTonic Holdings Ltd Class A Ordinary Shares

N/A

Current Price

$0.28

Market Cap

5.0M

Sector

N/A

ML Signal

N/A

Logo iSpecimen Inc.

ISPC

iSpecimen Inc.

N/A

Current Price

$1.16

Market Cap

4.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ITOC
ISPC
Founded
1998
2009
Country
China
United States
Employees
N/A
N/A
Industry
Precision Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0M
4.0M
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
ITOC
ISPC
Price
$0.28
$1.16
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 745.8K
439.6K
Earning Date
03-20-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 87.03
EPS
★ N/A
N/A
Revenue
N/A
★ $1,928,998.00
Revenue This Year
N/A
$638.10
Revenue Next Year
N/A
$17.50
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.22
$0.10
52 Week High
$1.15
$6.77

Technical Indicators

Market Signals
Indicator
ITOC
ISPC
Relative Strength Index (RSI) 43.83 27.64
Support Level $0.27 $0.27
Resistance Level $0.36 $1.94
Average True Range (ATR) 0.04 0.09
MACD -0.00 0.01
Stochastic Oscillator 8.76 6.29

Price Performance

Historical Comparison
ITOC
ISPC

About ITOC iTonic Holdings Ltd Class A Ordinary Shares

iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors. Its product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device, etc.

About ISPC iSpecimen Inc.

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.

Share on Social Networks: